Advertisement

Unreliability of the Duplex Scan in Diagnosing Corporeal Venous Occlusive Disease in Young Healthy Men With Erectile Deficiency

Published:November 16, 2017DOI:https://doi.org/10.1016/j.urology.2017.11.005

      Objective

      To define the role of cavernosal venous occlusive dysfunction (CVOD) as the only cause of erectile dysfunction (ED).

      Materials and Methods

      Patients meeting the CVOD criteria without any risk factors for organic ED were randomized into 2 groups; the end-diastolic velocity (EDV), peak systolic velocity (PSV), and resistive index (RI) of their cavernosal arteries were assessed using color duplex Doppler ultrasound (CDDU) after intracavernous injection (ICI) of 10 µg alprostadil. Group 1 (153 patients) underwent repeated CDDU + ICI assessments (a maximum of 3 rounds). Group 2 (149 patients) underwent CDDU + ICI before and after sexological counseling. The percentage data were analyzed using the Cochran-Mantel-Haenszel test; the numerical data were analyzed using the Wilcoxon test.

      Results

      For group 1, the PSVs (median values: first round 42 cm/s; second round 54 cm/s; third round 66 cm/s) and RIs (median values: first round 70%; second round 89%; third round 92%) increased significantly in each CDDU + ICI round, whereas the EDVs were significantly lower (median values: first round 11 cm/s; second round 5 cm/s; third round 1 cm/s). For group 2, the PSVs (median values: from 44 to 67 cm/s) and RIs (from 72% to 93%) increased significantly after sexological counseling, whereas the EDVs (median values: from 12 to 1 cm/s) were significantly lower.

      Conclusion

      Repeated CDDU + ICI and counseling strongly diminished the percentage of patients meeting the CVOD criteria, leading to the suspicion that CVOD is linked to psychological issues in highly selected young healthy men with ED.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lue T.
        Erectile dysfunction.
        N Engl J Med. 2000; 342: 1802-1813
        • Pathak R.A.
        • Rawal B.
        • Li Z.
        • Broderick G.A.
        Novel evidence-based classification of cavernous venous occlusive disease.
        J Urol. 2016; 196: 1223-1227
        • Montague D.K.
        • Jarow J.P.
        • Broderick G.A.
        • et al.
        The management of erectile dysfunction.
        (AUA University Guidelines; Available at:)
        • Sikka S.C.
        • Hellstrom W.J.
        • Brock G.
        • Morales A.M.
        Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound.
        J Sex Med. 2013; 10: 120-129
        • Teloken P.E.
        • Park K.
        • Parker M.
        • Guhring P.
        • Narus J.
        • Mulhall J.P.
        The false diagnosis of venous leak: prevalence and predictors.
        J Sex Med. 2011; 8: 2344-2349
        • Kim S.C.
        Recent advancement in diagnosis of vasculogenic impotence.
        Asian J Androl. 1999; 1: 37-43
        • Hsu G.L.
        • Chen H.S.
        • Hsieh C.H.
        • Lee W.Y.
        • Chen K.L.
        • Chang C.H.
        Salvaging penile venous stripping surgery.
        J Androl. 2010; 31: 250-260
        • McDonald J.H.
        Handbook of Biological Statistics.
        3rd ed. Sparky House Publishing, Baltimore, MD2014
        • Faul F.
        • Erdfelder E.
        • Buchner A.
        • Lang A.G.
        Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.
        Behav Res Methods. 2009; 41: 1149-1160
        • Rosen R.C.
        • Riley A.
        • Wagner G.
        • Osterloh I.H.
        • Kirkpatrick J.
        • Mishra A.
        The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.
        Urology. 1997; 49: 822-830
        • Ludwig W.
        • Phillips M.
        Organic causes of erectile dysfunction in men under 40.
        Urol Int. 2014; 92: 1-6
        • Cavallini G.
        • Scroppo F.I.
        • Zucchi A.
        Peak systolic velocity thresholds of cavernosal penile arteries in patients with and without risk factors for arterial erectile deficiency.
        Andrology. 2016; 4: 1187-1192
        • El-Sakka A.I.
        • Yassin A.A.
        Amelioration of penile fibrosis: myth or reality.
        J Androl. 2010; 31: 324-335
        • Broderick G.A.
        • Arger P.
        Duplex Doppler ultrasonography: noninvasive assessment of penile anatomy and function.
        Semin Roentgenol. 1993; 28: 43-56
        • Herbener T.E.
        • Seftel A.D.
        • Nehra A.
        • Goldstein I.
        Penile ultrasound.
        Semin Urol. 1994; 12: 320-332
        • Johnson J.
        • Panagioti M.
        • Bass J.
        • Ramsey L.
        • Harrison R.
        Resilience to emotional distress in response to failure, error or mistakes: a systematic review.
        Clin Psychol Rev. 2016; 21: 19-42
        • Virag R.
        • Bachir D.
        • Floresco J.
        • Galacteros F.
        • Dufour B.
        Ambulatory treatment and prevention of priapism using alpha-agonists. A propos of 172 cases.
        Chirurgie. 1997; 121: 648-652
        • Byrne M.
        • Doherty S.
        • Fridlund B.G.
        • et al.
        Sexual counselling for sexual problems in patients with cardiovascular disease.
        Cochrane Database Syst Rev. 2016; (CD010988)
        • Nelson C.J.
        • Hsiao W.
        • Balk E.
        • et al.
        Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
        J Sex Med. 2013; 10: 2559-2565
        • Cohen S.D.
        The challenge of erectile dysfunction management in the young man.
        Curr Urol Rep. 2015; 16: 84
        • Julian L.J.
        Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).
        Arthritis Care Res. 2011; 63: 467-572
        • Glina S.
        • Ghanem H.
        SOP: corpus cavernosum assessment (cavernosography/cavernosometry).
        J Sex Med. 2013; 10: 111-114
        • Cayan S.
        Primary penile venous leakage surgery with crural ligation in men with erectile dysfunction.
        J Urol. 2008; 180: 1056-1059
        • Daniel S.
        • Rainnie D.G.
        Stress modulation of opposing circuits in the bed nucleus of the stria terminalis.
        Neuropsychopharmacology. 2016; 41: 103-125
        • Andersson K.E.
        Pharmacology of penile erection.
        Pharmacol Rev. 2001; 53: 417-450
        • Andersson K.E.
        Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.
        Pharmacol Rev. 2011; 63: 811-859
        • Cellek S.
        Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction.
        Drugs Today (Barc). 2000; 36: 135-146
        • Hannan J.L.
        • Albersen M.
        • Kutlu O.
        • et al.
        Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.
        J Urol. 2013; 189: 1155-1161
        • White C.W.
        • Short J.L.
        • Ventura S.
        Rho kinase activation mediates adrenergic and cholinergic smooth muscle contractile responses in the mouse prostate gland.
        Eur J Pharmacol. 2013; 721: 313-321
        • De Rose A.F.
        • Giglio M.
        • Traverso P.
        • Lantieri P.
        • Carmignani G.
        Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy.
        Int J Impot Res. 2002; 14: 50-53